UNICA IRIS Institutional Research Information System

LOREFICE, LORENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 230.189
NA - Nord America 8.071
AS - Asia 3.428
SA - Sud America 439
Continente sconosciuto - Info sul continente non disponibili 415
AF - Africa 76
OC - Oceania 9
Totale 242.627
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 227.905
US - Stati Uniti d'America 7.937
CN - Cina 1.300
SG - Singapore 1.297
SE - Svezia 494
UA - Ucraina 454
DE - Germania 350
BR - Brasile 326
VN - Vietnam 285
FI - Finlandia 255
GB - Regno Unito 240
FR - Francia 197
HK - Hong Kong 101
IN - India 88
CA - Canada 79
NL - Olanda 79
KR - Corea 56
BD - Bangladesh 39
AR - Argentina 36
TR - Turchia 34
ES - Italia 30
RU - Federazione Russa 28
IQ - Iraq 27
JP - Giappone 26
MX - Messico 26
ZA - Sudafrica 25
EC - Ecuador 24
CZ - Repubblica Ceca 23
PL - Polonia 22
IR - Iran 18
MA - Marocco 18
AT - Austria 17
PK - Pakistan 16
BE - Belgio 15
LT - Lituania 14
UZ - Uzbekistan 14
CL - Cile 13
EU - Europa 13
SA - Arabia Saudita 13
CO - Colombia 12
PH - Filippine 12
ID - Indonesia 11
MY - Malesia 10
VE - Venezuela 10
AZ - Azerbaigian 9
IL - Israele 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
EG - Egitto 8
PS - Palestinian Territory 8
RO - Romania 8
HR - Croazia 7
JO - Giordania 7
KE - Kenya 7
TH - Thailandia 7
UY - Uruguay 7
DK - Danimarca 6
GR - Grecia 6
IE - Irlanda 6
CR - Costa Rica 5
HU - Ungheria 5
NP - Nepal 5
PY - Paraguay 5
BG - Bulgaria 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
JM - Giamaica 4
LB - Libano 4
MD - Moldavia 4
TN - Tunisia 4
ET - Etiopia 3
GE - Georgia 3
KW - Kuwait 3
KZ - Kazakistan 3
OM - Oman 3
PE - Perù 3
PR - Porto Rico 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
SV - El Salvador 3
TW - Taiwan 3
AL - Albania 2
BO - Bolivia 2
CI - Costa d'Avorio 2
GT - Guatemala 2
KG - Kirghizistan 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BT - Bhutan 1
CG - Congo 1
CY - Cipro 1
EE - Estonia 1
GP - Guadalupe 1
GY - Guiana 1
KH - Cambogia 1
Totale 242.213
Salva come PNG Salva come JPEG
Città #
Cagliari 222.977
Uta 4.082
Ashburn 887
Fairfield 669
Singapore 653
Woodbridge 509
Chandler 440
San Jose 434
Dallas 392
Houston 364
Wilmington 324
Boardman 308
Ann Arbor 290
Nyköping 277
Seattle 267
Beijing 245
Cambridge 212
Jacksonville 201
Helsinki 168
Dearborn 154
New York 149
Los Angeles 142
Santa Clara 130
Council Bluffs 125
Munich 115
Nanjing 111
Shanghai 104
The Dalles 100
Lauterbourg 93
Hong Kong 87
Ho Chi Minh City 86
Milan 84
Boston 82
Hefei 64
Hanoi 56
Seoul 55
Buffalo 51
Rome 44
Nanchang 42
Washington 39
Norwalk 38
Orem 38
São Paulo 38
Atlanta 37
Guangzhou 36
Redwood City 36
Sassari 36
Shenyang 35
Hebei 32
Chicago 31
San Diego 31
London 30
Toronto 29
Jiaxing 28
Phoenix 28
Columbus 27
Frankfurt am Main 26
Hangzhou 26
Tokyo 24
Stockholm 23
Verona 23
Changsha 22
Tianjin 22
Amsterdam 20
Dong Ket 20
Brooklyn 19
Chennai 19
Da Nang 19
Montreal 19
Warsaw 19
Denver 16
Jinan 16
Brno 15
Düsseldorf 15
Florence 15
Johannesburg 15
Redondo Beach 15
Turku 14
Manchester 13
Mexico City 13
Shenzhen 13
Taizhou 13
Kunming 12
Naples 12
Nuremberg 12
Zhengzhou 12
Detroit 11
Paris 11
Poplar 11
Tashkent 11
Curitiba 10
Domusnovas 10
Mountain View 10
Mumbai 10
New Delhi 10
Ningbo 10
Wuhan 10
Baku 9
City of London 9
Haiphong 9
Totale 236.805
Salva come PNG Salva come JPEG
Nome #
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis 5.994
Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles 5.253
Erratum to: Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population (Neurological Sciences, (2017), 38, 6, (1019-1025), 10.1007/s10072-017-2905-x 4.947
Evaluation of Stroop color word test as cognitive task to investigate cognitive motor interference during walking in Multiple Sclerosis 4.590
Quantitative assessment of alterations induced by spasticity on gait of individuals with multiple sclerosis using 3D gait analysis 4.497
Is Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western Sardinia 4.410
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients 4.313
The burden of multiple sclerosis variants in continental Italians and Sardinians 4.224
Overexpression of the cytokine BAFF and autoimmunity risk 4.141
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? 4.056
Assessment of geochemical factors in multiple sclerosis distribution in the South-Western Sardinia 4.026
Mycobacterium avium subsp. Paratuberculosis and multiple sclerosis in Sardinian patients: Epidemiology and clinical features 3.943
What do multiple sclerosis patients and their caregivers perceive as unmet needs? 3.901
Clinical Assessment of Gait in Individuals with Multiple Sclerosis Using Wearable Inertial Sensors: Comparison with Patient-Based Measure 3.847
Exploring cognitive motor interference in multiple sclerosis by the visual Stroop test 3.846
Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population 3.832
Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial 3.736
Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers 3.672
Walking improvements with nabiximols in patients with multiple sclerosis 3.654
Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection 3.624
Quantifying gait impairment in individuals affected by Charcot-Marie-Tooth disease: the usefulness of gait profile score and gait variable score 3.617
Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy 3.602
Factors influencing MS outcome in Sardinia: a clinical and genetic study 3.594
A genetic association study of two genes linked to neurodegeneration in a Sardinian multiple sclerosis population: The TARDBP Ala382Thr mutation and C9orf72 expansion 3.517
The impact of modifiable risk factors on lesion burden in patients with early multiple sclerosis 3.446
Impact of brain atrophy on walking in multiple sclerosis patients with low disability: a dual task study. 3.414
Impact of the media on future hope in multiple sclerosis 3.394
Long-term follow-up more than 10 years after HSCT: a monocentric experience 3.323
Association between brain atrophy and cognitive motor interference in multiple sclerosis 3.319
Multiple Sclerosis and environmental factors. 3.300
Are static and functional balance abilities related in individuals with Multiple Sclerosis? 3.300
Oral agents in multiple sclerosis 3.216
Influence of treatments in multiple sclerosis disability: a cohort study 3.192
‘Timed up and go’ and brain atrophy: a preliminary MRI study to assess functional mobility performance in multiple sclerosis 3.169
Top-down proteomic profiling of human saliva in multiple sclerosis patients 3.152
A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population 3.124
Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis 3.110
An unusual infection in MS patient treated with dimethyl fumarate: A case report of omphalitis 3.065
Brain volume in early MS patients with and without IgG oligoclonal bands in CSF 3.054
Smoothness of gait, but not spatio-temporal parameters, are altered in early stages of Multiple Sclerosis 3.003
Refining the connection between gait and cognition: training the body to improve the brain 2.990
Is There Any Relationship between Upper and Lower Limb Impairments in People with Multiple Sclerosis? A Kinematic Quantitative Analysis 2.988
Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population 2.981
Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population 2.888
Cognition in multiple sclerosis: Between cognitive reserve and brain volume 2.880
Hourly trends of physical activity in people with Multiple Sclerosis 2.866
Postural adaptation during a Nintendo Wii balance training 2.676
Perception of risk and shared decision making process in multiple sclerosis 2.658
Are static and dynamic balance abilities correlated in people with Multiple Sclerosis? 2.609
Pregnancy outcome in multiple sclerosis women treated with mitoxantrone 2.564
Vitamin D serum levels and balance are not related in Multiple Sclerosis 2.457
Evaluation of high doses of ascorbic acid efficacy in Charcot Marie Tooth type 1A 2.344
The cohort of the multiple sclerosis center of Cagliari 2.340
Attitude towards physical activity in patients with multiple sclerosis: a cohort study 2.336
Induction and escalation therapies in multiple sclerosis 2.290
Presence of oligoclonal IgG bands in Sardinians with multiple sclerosis is influenced by carriage of different HLA DRB1-DQB1 haplotypes 2.261
Thyroid antibodies in the CSF of Sardinian multiple sclerosis patients 2.242
Multiple sclerosis and fertilization in vitro with embryo transfer (FIVET): a case report 2.075
Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis 1.993
Epidemiology of multiple sclerosis in south-western Sardinia 1.941
The risk of bipolar disorders in multiple sclerosis 1.889
The impact of deep grey matter volume on cognition in Multiple Sclerosis 1.821
Coenzyme Q10 in the cerebrospinal fluid of multiple sclerosis patients 1.812
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study 1.790
Evaluation of FMR1 gene premutation in Sardinians multiple sclerosis 1.759
Facial synkinesis as a first symptom of multiple sclerosis 1.755
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 1.710
Occurence of autoimmune diseases in Sardinian multiple sclerosis patients and in their first degree relatives 1.653
Characterization of gait abnormalities in individuals affected by multiple sclerosis by means of the Gait Profile Score 1.650
Monoclonal antibodies: a target therapy for multiple sclerosis 1.498
Relationship between HLA DRB1-DQB1 haplotypes and oligoclonal IgG bands in Sardinians MS patients 1.411
Multiple sclerosis and bipolar disorders: the burden of comorbidity and its consequences on quality of life 1.402
Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire). 1.399
Autoimmune diseases in Sardinian multiple sclerosis patients and in their first degree relatives 1.360
Delayed effect of age at onset on disability progression in multiple sclerosis 1.312
Coenzyme Q10 in the CSF of MS patients 1.145
Q10 in the CSF of MS patients 1.135
Gait initiation evaluation in multiple sclerosis 1.118
1H-NMR-Based Metabolomics in Autism Spectrum Disorder and Pediatric Acute-Onset Neuropsychiatric Syndrome 1.072
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 1.070
Postural sway analysis as tool to assess balance impairments in individuals with multiple sclerosis 1.068
Effects of Pregnancy and Breastfeeding on Clinical Outcomes and MRI Measurements of Women with Multiple Sclerosis: An Exploratory Real-World Cohort Study 1.042
Epidemiology of multiple sclerosis in south western Sardinia: nature versus nurture 1.034
Optic Neuritis: a common MS symptom or a peculiar phenotype? 1.022
Sex Hormones as Key Modulators of the Immune Response in Multiple Sclerosis: A Review 948
Mitoxantrone treatment in patients with early relapsing-remitting multiple sclerosis 935
Optic Neuritis: a common MS symptom or a specific phenotype? 861
Event-related potentials and deep grey matter atrophy in multiple sclerosis: Exploring the possible associations with cognition 809
null 756
Leukocyte telomere length in women with multiple sclerosis: Comparison with healthy women during pregnancy and puerperium 747
Impact of Menopause in Patients with Multiple Sclerosis: Current Perspectives 741
Evolution of teriflunomide use in multiple sclerosis: A real-world experience 668
The impact of the secondary infections in ICU patients affected by COVID-19 during three different phases of the SARS-CoV-2 pandemic 618
Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis 399
Role of geo-chemical environmental factors in multiple sclerosis distribution in the south-western Sardinia 298
Evaluation of the Metabolomics Profile in Charcot–Marie–Tooth (CMT) Patients: Novel Potential Biomarkers 124
Totale 242.627
Salva come PNG Salva come JPEG
Categoria #
all - tutte 285.344
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 285.344
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20229.362 0 696 461 995 913 567 508 535 1.181 1.097 1.293 1.116
2022/202314.125 1.393 2.254 2.025 1.159 1.054 1.359 558 1.092 741 789 1.071 630
2023/202414.464 910 926 682 1.154 1.391 2.454 1.392 1.408 686 964 1.233 1.264
2024/202540.889 13.972 13.782 4.243 2.514 1.416 1.628 2.067 166 294 298 231 278
2025/20267.415 603 356 692 659 620 521 1.228 700 402 723 443 468
2026/2027327 106 221 0 0 0 0 0 0 0 0 0 0
Totale 242.627